Chinese electric vehicle manufacturer Li Auto, formerly known as CHJ Automotive, rang the Nasdaq opening bell in celebration of its Initial Public Offering last night, which raised $1.1 billion.

Li rocketed nearly 50 percent to trade above $16 on Thursday after pricing their IPO at $11.50 an American Depositary Share. Li last week set an IPO range of between $8 and $10.

Li said in its IPO prospectus that it would use most of the proceeds raised for capital expenditures and research and development.

The five-year-old carmaker started mass production of its inaugural model, the Li ONE, last year. The six-seat electric SUV sold at a subsidized price of 328,000 yuan ($46,800). By the end of June, it had delivered more than 10,400 units.

Li Auto’s revenue has surged as it moves toward profitability. Its first-quarter revenue of $120 million was triple that for all of 2019, according to the company’s filings. While it lost $344 million in 2019, its net loss in the first quarter of 2020 shrank to $11 million.

The IPO arrived amid a surge of investor interest in electric vehicle makers. Tesla’s shares have risen sharply in the last few months. At the same time, Li Auto’s domestic rival Nio, which raised a similar amount in a $1 billion float in New York back in 2018, has seen its stock price rally.

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Another Catholic diocese seeks bankruptcy after abuse deals

HARRISBURG, Pa. — The Roman Catholic Diocese of Harrisburg, Pennsylvania, filed for bankruptcy Wednesday, six months after disclosing it had paid millions of dollars to people sexually abused as children by its clerics. The diocese joins at least 20 others…

Graying of society attracting foreign pension firms

Multi-layered system to help reform and streamline the policy regime The COVID-19 pandemic has forced China’s financial system to tackle immediate challenges including the very survival of some businesses. But top regulators have not ignored a longer term issue that…

Samsung Electronics trials work-from-home as South Korea battles virus resurgence: official

SEOUL (Reuters) – Samsung Electronics Co Ltd (005930.KS) plans to allow some workers in South Korea to work from home in September under a pilot programme, a company official said on Thursday, as the country battles a resurgence in novel…

Gilead shares slide after FDA knocks back rheumatoid arthritis drug

(Reuters) – Shares of Gilead Sciences (GILD.O) fell 3% after the U.S. Food and Drug Administration declined to approve its experimental rheumatoid arthritis treatment, a major setback for one of the drugmaker’s important products. Gilead’s antiviral medicine remdesivir has put…